This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction

Clinical trial NCT06853223 · RECRUITING

Trial details

NCT number: NCT06853223
Sponsor: University of California, San Francisco
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Graft Dysfunction Lung Transplantation Acute Lung Injury(ALI)Natural Killer Cell Mediated Immunity

Start date: 2025-12-07
Primary completion: 2028-04-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.